The scientist’s investigation covers issues in Internal medicine, Endocrinology, Renin–angiotensin system, Angiotensin II and Receptor. His Internal medicine study which covers Cardiology that intersects with Transplantation. His research investigates the link between Endocrinology and topics such as Endothelin 1 that cross with problems in Endothelin receptor and Preeclampsia.
His work deals with themes such as Aldosterone, Angiotensin-converting enzyme, ACE inhibitor, Circulatory system and Pharmacology, which intersect with Renin–angiotensin system. His work in Angiotensin II receptor type 1 and Angiotensin receptor is related to Angiotensin II. His biological study spans a wide range of topics, including Signal transduction, Cell biology and In vivo.
His primary scientific interests are in Internal medicine, Endocrinology, Renin–angiotensin system, Angiotensin II and Receptor. His Internal medicine study frequently draws connections to other fields, such as Cardiology. His Angiotensin II receptor type 1, Kidney, Aldosterone, Angiotensin-converting enzyme and Angiotensin receptor investigations are all subjects of Endocrinology research.
The Renin–angiotensin system study combines topics in areas such as Vasoconstriction, Blockade and Pharmacology. His Angiotensin II study incorporates themes from Irbesartan, Endothelium and Receptor antagonist. The concepts of his Receptor study are interwoven with issues in Diabetes mellitus, Vascular smooth muscle, Intracellular and In vivo.
His primary areas of study are Internal medicine, Endocrinology, Renin–angiotensin system, Pharmacology and Preeclampsia. A.H. Jan Danser has researched Internal medicine in several fields, including Diabetes mellitus, Downregulation and upregulation and Cardiology. Endocrinology is closely attributed to Sildenafil in his work.
His Renin–angiotensin system research incorporates elements of Receptor, Angiotensin II, Aldosterone and Reabsorption. His Pharmacology study combines topics from a wide range of disciplines, such as Coronary arteries, Sitaxentan, Phosphodiesterase and Small interfering RNA. His Preeclampsia research includes themes of Vascular endothelial growth factor A, Vascular endothelial growth factor, Fetus and Nephropathy.
Pharmacology, Renin–angiotensin system, Internal medicine, Receptor and Angiotensin II are his primary areas of study. His Renin–angiotensin system study combines topics in areas such as Acute kidney injury, RNAi Therapeutics, Small interfering RNA and Heart disease. His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Cardiology.
His research integrates issues of Ex vivo, Perfusion and Vinpocetine in his study of Endocrinology. His study in the field of Sumatriptan also crosses realms of Lasmiditan. His Angiotensin II research includes elements of Blockade, Combination therapy, Homeostasis and Genetic enhancement.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Angiotensin-Converting Enzyme in the Human Heart: Effect of the Deletion/Insertion Polymorphism
A.H. Jan Danser;Maarten A.D.H. Schalekamp;Willem A. Bax;Antoinette Maassen van den Brink.
Hypertension Renin–Angiotensin–Aldosterone System Alterations
Luuk te Riet;Joep H.M. van Esch;Anton J.M. Roks;Anton H. van den Meiracker.
Circulation Research (2015)
Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women
Heribert Schunkert;A.H. Jan Danser;Hans-Werner Hense;Frans H.M. Derkx.
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
A.H. Jan Danser;Murray Epstein;Daniel Batlle.
Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats
Bernhard Pilz;Erdenechimeg Shagdarsuren;Maren Wellner;Anette Fiebeler.
Renin, prorenin and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy
A. H. J. Danser;M. A. Van Den Dorpel;J. Deinum;F. H. M. Derkx.
The Journal of Clinical Endocrinology and Metabolism (1989)
Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats
David L. Feldman;Liang Jin;Hong Xuan;Aurelie Contrepas.
Renin, prorenin and the putative (pro)renin receptor.
A.H. Jan Danser;Jaap Deinum.
Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis.
A. H. J. Danser;J. P. Van Kats;P. J. J. Admiraal;F. H. M. Derkx.
Prorenin and Renin-Induced Extracellular Signal-Regulated Kinase 1/2 Activation in Monocytes Is Not Blocked by Aliskiren or the Handle-Region Peptide
Sandra Feldt;Wendy W. Batenburg;Istvan Mazak;Ulrike Maschke.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: